Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Zalewski Thomas A. — Aquestive Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Zalewski Thomas A.

Zalewski Thomas A.

Chief Legal Officer at Aquestive Therapeutics, Inc. · on record since Apr 10, 2026

Insider trading activity of Zalewski Thomas A.

Transactions on record: 2; since May 19, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 19, 2026

Figures computed from official regulatory filings — methodology.

Companies where Zalewski Thomas A. has traded

Aquestive Therapeutics, Inc.2 tx · May 19, 2026

Track record of Zalewski Thomas A.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Zalewski Thomas A.

Co-insiders of Zalewski Thomas A.

Barber DanielAquestive Therapeutics, Inc.
Boyd Peter E.Aquestive Therapeutics, Inc.
BRAENDER LORI JAquestive Therapeutics, Inc.
Bratton Capital Inc.Aquestive Therapeutics, Inc.
Bratton Capital Management, L.P.Aquestive Therapeutics, Inc.
BRATTON DOUGLAS KAquestive Therapeutics, Inc.
BROWN GREGORY BAquestive Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Cioffi MelinaAquestive Therapeutics, Inc.

Cochran JohnAquestive Therapeutics, Inc.

COSTA SANTO JAquestive Therapeutics, Inc.

Davis Matthew W.Aquestive Therapeutics, Inc.

Greenhawt Matthew J.Aquestive Therapeutics, Inc.

Jenkins Abigail L.Aquestive Therapeutics, Inc.

Jung CassieAquestive Therapeutics, Inc.

Kendall Keith JAquestive Therapeutics, Inc.

Korczynski SherryAquestive Therapeutics, Inc.

Kraus Carl NAquestive Therapeutics, Inc.

Krop JulieAquestive Therapeutics, Inc.

Lurker NancyAquestive Therapeutics, Inc.

Marshall Ken W.Aquestive Therapeutics, Inc.

Maxwell John T.Aquestive Therapeutics, Inc.

Monoline Partners, L.P.Aquestive Therapeutics, Inc.

Monoline RX III, L.P.Aquestive Therapeutics, Inc.

MonoLine RX II, L.P.Aquestive Therapeutics, Inc.

MonoLine RX, L.P.Aquestive Therapeutics, Inc.

MonoSol Rx Genpar, L.P.Aquestive Therapeutics, Inc.

MORRIS TIMOTHY EAquestive Therapeutics, Inc.

MRX Partners, LLCAquestive Therapeutics, Inc.

Schobel Alexander MarkAquestive Therapeutics, Inc.

Scibetta James SAquestive Therapeutics, Inc.

Slatko Gary HAquestive Therapeutics, Inc.

Taglietti MarcoAquestive Therapeutics, Inc.

TOTH A ERNEST JRAquestive Therapeutics, Inc.

Truitt KennethAquestive Therapeutics, Inc.

Wargacki StephenAquestive Therapeutics, Inc.

Wood TheresaAquestive Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aquestive Therapeutics, Inc.	May 19, 2026	AwardD	75,000	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	May 19, 2026	Award	100,000	0.00 USD	$0	SEC